CLS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Celestica Inc (CLS) is a good buy for a beginner investor with a long-term investment strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst ratings, hedge fund buying trends, and potential for growth in the AI-driven market make it a compelling choice. Despite some technical indicators showing neutral or slightly bearish trends, the long-term growth potential outweighs short-term fluctuations.
The MACD is below 0 and negatively contracting (-2.442), indicating a bearish trend. RSI is at 36.048, which is neutral but leaning towards oversold territory. Moving averages are converging, suggesting no clear trend. Key support is at 257.117, and resistance is at 300.742. The stock has a 70% chance of gaining 4.84% in the next month.
Hedge funds are significantly increasing their positions in CLS, with a 309.07% increase in buying activity last quarter.
Analysts have raised price targets, with Barclays setting a high target of $391 and BofA initiating a $400 target, citing strong AI-driven growth potential.
Financial performance in Q4 2025 showed impressive growth, with revenue up 43.57% YoY and net income up 76.33% YoY.
The MACD and RSI indicate potential short-term bearishness.
Competition risks from Inventec in AI server production could impact future growth.
No recent congress trading data or AI Stock Picker/SwingMax signals to reinforce a strong buy.
In Q4 2025, Celestica reported revenue growth of 43.57% YoY to $3.65 billion, net income growth of 76.33% YoY to $267.5 million, and EPS growth of 79.07% YoY to $2.31. Gross margin also improved to 11.52%, up 2.67% YoY, reflecting strong operational performance.
Analysts are generally positive, with multiple firms raising price targets. Barclays raised the target to $391, citing conservative guidance that could be revised upward. BofA initiated coverage with a $400 target, emphasizing growth in AI-driven markets. RBC Capital reiterated an Outperform rating, noting strong demand momentum through 2027. However, TD Cowen and Citi have slightly lower targets, reflecting a more cautious stance.
